首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1452738

全球馬保健品市場規模、佔有率、成長分析、按產品類型、按適應症分類 - 產業預測 (2024-2031)

Global Equine Healthcare Market Size, Share, Growth Analysis, By Product Type(Vaccines, Pharmaceuticals), By Indication(Musculoskeletal Disorders, Internal Medicine) - Industry Forecast 2024-2031

出版日期: 2024年03月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球馬保健市場規模為28.7億美元，從2023年的33.6億美元成長到2031年的117億美元，預測期內（2024-2031年）預計複合年成長率為16.9%。

多種因素促進了馬醫療保健行業的顯著成長。其中包括對賽馬和體育行業的投資、馬疾病的流行以及行業相關人員對馬醫療保健服務日益成長的需求。委內瑞拉馬腦脊髓炎、狂犬病、西尼羅熱病和馬流感等馬疾病在全球蔓延，需要有效的預防和治療方案（OIE於2021年發布）。

馬業受到 COVID-19 大流行的嚴重影響。政府的限制措施暫時關閉了一些設施，並使營運商陷入財務困境。

馬獸醫已經習慣了基於遠端醫療的程序，因此當失業率上升時，對馬健康的擔憂就凸顯出來。不過，這些影響是暫時的，市場正穩定復甦。

由於認知到動物保健對人類和動物都很重要，公眾對動物保健的認知將在預測期內提高。為了阻止疾病從動物傳播給人類，政府和私人組織正在對動物保健基礎設施進行重大投資。例如，美國農業部在動物營養和健康方面花費了 30 億美元。

馬匹對於越野騎行和騎馬課程等休閒來說是必不可少的，而馬匹的維護、供應和活動的成本很高。這些努力顯著增加了就業機會和經濟價值。擁有最先進設備以及馬匹醫療和診斷用品的獸醫醫院的存在進一步支持了市場擴張。利物浦大學菲利普·萊弗休姆馬科醫院等知名機構提供的最新診斷工具正在改善馬匹護理和治療選擇。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Zoetis Inc.
Merck Animal Health
Boehringer Ingelheim International GmbH
Elanco Animal Health
Bayer AG
Ceva Sante Animale
Virbac
Dechra Pharmaceuticals PLC
IDEXX Laboratories, Inc.
Vetoquinol SA
Norbrook Laboratories Limited
EQUINE PRODUCTS UK LTD
KRKA
HIPRA
Luitpold Pharmaceuticals, Inc.

簡介目錄

Product Code: SQMIG35G2223

The Global Equine Healthcare Market size was valued at USD 2.87 billion in 2022 and is poised to grow from USD 3.36 billion in 2023 to USD 11.70 billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).

A number of causes are contributing to the significant growth of the equine healthcare sector. These include investments in the equine racing and sports sector, an increase in the prevalence of equine diseases, and the growing demand for equine healthcare services from industry stakeholders. Effective prevention and treatment options are in high demand due to the global expansion of horse diseases such Venezuelan equine encephalomyelitis, rabies, West Nile fever, and equine influenza, as stated by the OIE in 2021.

The equine sector was significantly impacted by the COVID-19 pandemic. Government regulations caused several facilities to close temporarily, which put operators in a difficult financial situation.

Equine veterinarians were accustomed to telehealth-based procedures, and when unemployment rates rose, worries about the wellbeing of the horses surfaced. These effects, meanwhile, were only temporary, as the market steadily recovered.

Increased public awareness of animal healthcare throughout the forecast period will be fueled by knowledge of its significance for both people and animals. To stop diseases from spreading from animals to people, governments and private organizations are making large investments in the infrastructure of animal healthcare. The U.S. Department of Agriculture, for instance, has spent $3 billion on the nutrition and health of animals.

Horses are essential to leisure pursuits such as trail rides and riding classes, which increases the cost of horse maintenance, supplies, and activity fees. These endeavors significantly enhance the generation of jobs and economic value. The availability of veterinary institutions with state-of-the-art equipment and medical and diagnostic supplies for horses drives market expansion even more. Modern diagnostic tools are provided by renowned establishments like the Philip Leverhulme Equine Hospital at the University of Liverpool, improving equine care and therapy alternatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Equine Healthcare Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Equine Healthcare Market Segmental Analysis

There are four main segments in the global equine healthcare market: Product Type, Indication, Distribution Channel, and Region. The market is divided into the following segments based on product type: software & services, pharmaceuticals, medicinal feed additives, vaccines, and others. The market is divided into segments based on indication, including tetanus, internal medicine, equine herpes virus, equine encephalomyelitis, equine influenza, west nile virus, and musculoskeletal disorders. The market is divided into three segments based on distribution: e-commerce, veterinary hospitals & clinics, and others. The market is divided into four regions: North America, Europe, Asia-Pacific, and Latin America.

Drivers of the Global Equine Healthcare Market

The need for cutting-edge healthcare solutions is being driven by the growing knowledge of and concern for the health and welfare of horses, particularly in high-performance industries like racing, sports, and leisure.

Restraints in the Global Equine Healthcare Market

The timely and effective delivery of healthcare may be impacted in some places by a lack of specialized horse veterinarians and medical facilities.

Market Trends of the Global Equine Healthcare Market

Personalized Healthcare Solutions: A trend toward more individualized treatment regimens and approaches is now observed in the horse healthcare industry. More and more, specialized treatment plans, genetic testing, and advanced diagnostics are being used to address the unique health needs of individual horses.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Equine Healthcare Market by Product Type

Market Overview
Vaccines
Pharmaceuticals
Medicinal Feed Additives
Diagnostics
Software & Services
and Others

Global Equine Healthcare Market by Indication

Market Overview
Musculoskeletal Disorders
Internal Medicine
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
and Others.

Global Equine Healthcare Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dechra Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEXX Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norbrook Laboratories Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EQUINE PRODUCTS UK LTD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KRKA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HIPRA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luitpold Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments